Search articles

Parliament goes blue. What’s in store for business?

Posted by , Partner

The speculation is over. What’s in store for businesses across the UK now?

Read more

29 October 2019 0 Comments Posted in Brexit, Corporate & Commercial, Opinion

What the Queen said about Life Sciences

Posted by , Partner

Recent weeks have in the news been dominated by Brexit, the withdrawal agreement, the suspension of Parliament and in the end the Queen’s speech.

Read more

1 March 2019 0 Comments Posted in Brexit, Opinion

Ways to ensure business as usual in a no deal Brexit scenario

Posted by , Partner

Brexit

The Brexit task group at UK law firm Royds Withy King is advising business owners of the steps they need to take to make sure they can continue to trade with the EU in the event of a no deal Brexit.

Read more

Are your commercial contracts Brexit ready?

Posted by , Partner

Your commercial contracts may be vulnerable to political changes. Have you considered if you need to renegotiate? Or engage with your supply chain? Or add extra protection for your IP?

Read more

5 December 2018 0 Comments Posted in Case Studies, Corporate & Commercial

Negotiation, drafting and review of a contract for a new orphan drug

Posted by , Partner

Long standing client from charity sector with a patient data base, came to us with the need for legal advice. It had been approached by a European Pharmaceutical, (EP). EP wanted to have access to our client’s database in order …

Read more

0 Comments Posted in Brexit, Events

Life after Brexit: the challenges and opportunities facing the UK’s Life Sciences sector

Posted by , Partner

“The life sciences industry represents one of the dominant economic sectors in the UK.
It brings significant jobs and growth to virtually every region. To retain the UK’s competitive edge in this sector, there is a requirement for sustained effort over a longer period of time”.
Professor Sir John Bell, Regius Professor of Medicine, University of Oxford and Chairman, Office for the Strategic Coordination of Health Research.

Read more

1 November 2018 0 Comments Posted in Factsheets, Technology & Media

GDPR guidance for life science businesses collecting and processing patient data

Posted by , Partner

Read more

22 October 2018 0 Comments Posted in Opinion, Technology & media

What to take from the annual meeting of the Medicon Valley Alliance

Posted by , Partner

On 11th October 2018 Thomas Bjørn and Claus Andersen attended the annual meeting of the Medicon Valley Alliance.

Read more

18 October 2018 0 Comments Posted in Brexit, Opinion

Brexit – while we are waiting for certainty

Posted by , Partner

Brexit uncertainty

This weekend I attended a conference in Copenhagen hosted by the Conservative party in Denmark and the Europe movement. The conference was about the implications of Brexit. The speakers included officials from the Danish CBI (“Dansk Industri”), Danish Shipping (Danske Rederier) and Dominic Schroeder, who is the UK Ambassador to Denmark.

Read more

16 October 2018 0 Comments Posted in Brexit, Opinion

Have you considered these 10 things about Brexit?

Posted by , Partner

Brexit

Claus Andersen, Partner, and Abdul Basith, Paralegal, look at 10 interesting but not often thought of facts about Brexit

Read more

18 July 2018 0 Comments Posted in Brexit

Royds Withy King provides input into the CBI’s report on post-brexit immigration policies

Posted by , Partner

Being able to attract the right talent is hugely important to our clients, to our firm and to the wider legal industry. Our clients’ employees and our own lawyers and support staff are recruited from inside and outside the UK, including from the EU and other overseas countries. 

Read more

21 November 2017 0 Comments Posted in News

Departure of European Medicines Agency takes 40,000 London hotel rooms with it

Posted by , Partner

Oxford genetics

The EU yesterday (20 November) announced that the European Medicines Agency will relocate from its Docklands home to Amsterdam when the UK leaves the EU in 2019, taking with it around 1,000 high value jobs. The move will, says Royds …

Read more

Search articles